Remarkably, further subgroup analyses indicated that such relationships between mTOR/p-mTOR expression and worse survival of ESCC were not substantially altered by different endpoints, cut-off values and follow-up periods. The gene discussed is MTOR; the disease is esophageal squamous cell carcinoma.